Apoc - OmicsDI

Show results for

Unknown (194)
Transcriptomics (41)
Proteomics (22)
Genomics (10)
Metabolomics (1)

Organisms

Homo sapiens (28)
Mus musculus (12)
Rattus norvegicus (4)
Alphavirus (4)
Anemia (4)
Archaea (4)
Bacteria (4)
Betaherpesvirinae (4)
Borrelia (4)
Chlamydomonas reinhardtii (4)
Chlorella vulgaris (4)
Clostridium perfringens (4)
Dengue virus (4)
Eukaryota (4)
Hepatitis B virus (4)
Human alphaherpesvirus 1 (4)
Human betaherpesvirus 5 (4)
Influenza A virus (4)
Influenza C virus (4)
Japanese encephalitis virus group (4)
Kamptonema sp. (4)
Listeria monocytogenes (4)
Mammarenavirus (4)
Miscanthus x giganteus (4)
Sus scrofa (3)
Canis lupus familiaris (2)
Metallosphaera sedula DSM 5348 (1)
Oryza sativa (1)
Betula platyphylla (1)
Gallus gallus (1)

Organisms

Mus musculus (1)
Homo sapiens (1)

Repository

biostudies-arrayexpress (42)
MassIVE (8)
iProX (5)
PanoramaPublic (4)
pride (4)
EGA (3)
geo (3)
ENA (2)
EVA (1)
MetaboLights (1)
PAXDB (1)

Tissue

Blood serum (2)
Aortic valve (1)
Blood plasma (1)

Disease

Cardiovascular system disease (1)
Persistent severe asthma (1)

Technology Type

Mass Spectrometry (4)
Shotgun proteomics (3)
NMR spectroscopy (1)
Gel-based experiment (1)

Instrument Platform

Illumina HiSeq 2500 (3)
LTQ Orbitrap Velos (2)
Q Exactive Plus (2)
10x Chromium (1)
Illumina NovaSeq 6000 (1)
Illumina HiSeq 2000 (1)
Illumina CanineHD (1)
LTQ Orbitrap Elite (1)
Q Exactive (1)
TimsTOF fleX (1)
TripleTOF 5600 (1)
Bruker (1)

Publication Date

2012 (8)
2014 (7)
2020 (7)
2015 (5)
2021 (4)
2017 (4)
2013 (4)
2011 (4)
2008 (4)
2025 (3)
2009 (3)
2019 (3)
2022 (3)
2018 (2)
2024 (2)
2016 (1)
2010 (1)
2007 (1)
2023 (1)

UNIPROT ID/AC

5811.TGME49_004050 (1)
5811.TGME49_005250 (1)
5811.TGME49_027920 (1)
5811.TGME49_044150 (1)
5811.TGME49_054560 (1)
5811.TGME49_094800 (1)
5811.TGME49_102050 (1)
5811.TGME49_119870 (1)
5811.TGME49_119920 (1)
A0A0F7UMP6_TOXGV (1)
A0A0F7UN03_TOXGV (1)
A0A0F7UNS9_TOXGV (1)
A0A0F7UNU4_TOXGV (1)
A0A0F7URF8_TOXGV (1)
A0A0F7US18_TOXGV (1)
A0A0F7USK4_TOXGV (1)
A0A0F7USU7_TOXGV (1)
A0A0F7UTC9_TOXGV (1)
A0A0F7UTQ6_TOXGV (1)
A0A0F7UTS9_TOXGV (1)
A0A0F7UU04_TOXGV (1)
A0A0F7UU07_TOXGV (1)
A0A0F7UUM4_TOXGV (1)
A0A0F7UVN4_TOXGV (1)
A0A0F7UWM4_TOXGV (1)
A0A0F7UXU1_TOXGV (1)
A0A0F7UXX2_TOXGV (1)
A0A0F7UY31_TOXGV (1)
A0A0F7UYG5_TOXGV (1)
A0A0F7UZH2_TOXGV (1)

CHEBI ID

CHEBI:28831 (1)
CHEBI:30751 (1)
CHEBI:18186 (1)
CHEBI:17234 (1)
CHEBI:28300 (1)
CHEBI:16236 (1)
CHEBI:16977 (1)
CHEBI:25017 (1)
CHEBI:28044 (1)
CHEBI:27266 (1)
CHEBI:15971 (1)
CHEBI:15366 (1)
CHEBI:78320 (1)
CHEBI:16737 (1)
CHEBI:16919 (1)
CHEBI:20067 (1)

Metabolite Name

Ethanol (1)
Propanol (1)
Formate (1)
Acetate (1)
Leucine (1)
3-hydroxybutyrate (1)
L-alanine (1)
Valine (1)
L-histidine (1)
Lactate (1)
Tyrosine (1)
Phenylalanine (1)
Glutamine (1)
Glucose (1)
Creatinine (1)
Creatine (1)

First Public Date

2019 (1)
2014 (1)

Study type

Transcription profiling by array (22)
RNA-seq of coding RNA (6)
Other (4)
ChIP-chip by tiling array (3)
ChIP-seq (2)
Unknown experiment type (1)
Animal - High-throughput sequencing (1)
Genotyping by array (1)
RNA-seq of coding RNA from single cells (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2017 (22)
2016 (20)
2022 (20)
2021 (19)
2015 (16)
2013 (14)
2014 (13)
2008 (13)
2019 (13)
2025 (11)
2018 (11)
2012 (11)
2023 (11)
2010 (9)
2024 (9)
2020 (9)
2011 (6)
2009 (5)
2007 (2)
2026 (1)
2006 (1)

Lab affiliation

Center for Interdisciplinary Cardiovascular Sciences, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA (1)
Functional proteomis lab, Life Sciences Dept., University of Siena (1)
Jiangsu Key Laboratory of Pediatric Respiratory Disease (1)
NIST Charleston (1)

Tags

xref:PubMed:31092690 (1)
xref:PubMed:22236405 (1)

Previous page
1 / 27
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 27
Next page

Sort by:

Relevance

Page size

ApoC-III is a novel inducer of human valvular calcification

Pharmacological interventions to treat valvular calcification are not currently part of clinical guidelines. Low-density lipoprotein lowering therapies to treat calcific aortic valve disease (CAVD) failed in clinical trials. However, apolipoproteins are known promotors of atherosclerosis and may pla...

ORGANISM(S): Homo sapiens (Human)

2020-12-14 | PXD021858 | Pride

ApoE determines the metabolic fate of apoC-III

PRJNA543116 | ENA

ApoE determines the metabolic fate of apoC-III

Hypertriglyceridemia results from accumulation of triglyceride (TG)-rich lipoproteins (TRLs) in the circulation and is associated with increased cardiovascular disease risk. ApoC-III is an apolipoprotein on TRLs and a prominent negative regulator of TG catabolism. We recently established that in viv...

ORGANISM(S): Mus musculus

2019-05-24 | GSE131284 | GEO

ApoC-III proteoforms are associated with better lipid, inflammatory, and glucose profiles independent of total apoC-III.

Not available

S-EPMC11619673 | biostudies-literature

APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism.

Not available

S-EPMC9947064 | biostudies-literature

Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide.

Not available

S-EPMC4727155 | biostudies-literature

APoc: large-scale identification of similar protein pockets.